XML 68 R58.htm IDEA: XBRL DOCUMENT v3.21.1
Commitments and Contingencies - Contingencies - Additional Information (Detail)
€ in Millions, $ in Millions
1 Months Ended 3 Months Ended 12 Months Ended
Nov. 20, 2020
EUR (€)
Oct. 21, 2019
USD ($)
Number
Aug. 21, 2017
USD ($)
Jul. 15, 2015
USD ($)
May 31, 2019
USD ($)
Aug. 31, 2012
USD ($)
Dec. 31, 2010
USD ($)
Aug. 31, 2008
USD ($)
Mar. 31, 2021
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2014
USD ($)
Sep. 01, 2020
USD ($)
Jan. 31, 2009
USD ($)
Jul. 31, 2008
USD ($)
Feb. 28, 2005
USD ($)
Commitment And Contingencies [Line Items]                              
Damages assessment                 $ 235.5            
Annual sales at the time of settlement                       $ 700.0 $ 350.0    
Annual sales of Effexor     $ 2,600.0                        
Annual sales of Lamictal                           $ 2,300.0 $ 950.0
Annual sales of Aggrenox       $ 1.1       $ 416.0              
Annual sales of Actos           $ 2,800.0 $ 3,700.0                
Annual sales of Acto plus           $ 430.0 $ 500.0                
Annual Sales Of Sensipar                   $ 1,400.0          
Litigation settlement amount awarded cash amount   $ 20.0                          
Annual Sales Of Copaxone                     $ 380.0        
Fines Imposed In Period | € € 60.5                            
Opioid Litigation [Member]                              
Commitment And Contingencies [Line Items]                              
Litigation settlement amount   $ 25.0     $ 85.0                    
Litigation settlement amount awarded distribution period   3 years                          
Litigation settlement amount awarded number of installments | Number   4                          
Litigation settlement amount awarded cash amount distribution period   3 years                          
Nationwide Settlement [Member]                              
Commitment And Contingencies [Line Items]                              
Litigation settlement amount   $ 23,000.0                          
Litigation settlement amount awarded distribution period   10 years                          
Litigation settlement amount awarded cash amount   $ 250.0                          
Litigation settlement amount awarded cash amount distribution period   10 years                          
Eosinophilic Esophagitis [Member]                              
Commitment And Contingencies [Line Items]                              
Damage claimed                 200.0            
Eosinophilic Esophagitis [Member] | United States [Member]                              
Commitment And Contingencies [Line Items]                              
Damage claimed                 150.0            
Eosinophilic Esophagitis [Member] | Europe [Member]                              
Commitment And Contingencies [Line Items]                              
Damage claimed                 $ 50.0            
AndroGel Rate at 1% [Member]                              
Commitment And Contingencies [Line Items]                              
Annual sales at the time of settlement                         $ 140.0